File – This September 2020 photo, provided by Johnson & Johnson, shows a single-dose COVID-19 vaccine being developed by the company. A.P. European stocks held lower on Tuesday, with traders losing momentum after halting key coronavirus trials waiting for earnings from some of the world’s leading banks. Stocks Europe 600 …
Read More »
A general view of the Wopakat refinery in Rotterdam port, Rotterdam-based Petrol, diesel and other major oil and oil companies in the Netherlands, including BP, Gwenner Petroleum, VPR Engineering, ExxonMobil or ExxonMobil, ESSO and ShellW. Dean Mohtoroplos / Getty Images European stocks rallied on Wednesday by oil companies and pharmaceutical …
Read More »
Text size Dreamstime Older adults who participated in Moderna‘s Phase 1 trial of its Covid-19 vaccine responded just as well as younger adults, according to data, the biotech company presented Wednesday morning to a key Centers for Disease Control and Prevention Advisory panel. This is important because Covid-19 is not …
Read More »
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »
Despite the urgency of beating COVID-19, health officials may delay the development of an effective vaccine. Authorities in the U.S. and elsewhere have yet to authorize an ethical charge investigation procedure called “trials with human challenge.” Challenge tests deliberately involve volunteers with the disease – which explains the official retention …
Read More »